German pharma firm Stada plans to launch its initial public offering (IPO) as soon as Wednesday, two people familiar with the ...

Private equity funds that own German drugmaker Stada Arzneimittel AG have decided to postpone its planned initial public ...

Stada Arzneimittel AG’s private equity owners are pushing back a planned initial public offering of the German drugmaker ...

FRANKFURT, March 18 (Reuters) - German pharmaceuticals company Stada has postponed a planned initial public offering (IPO) in Frankfurt because of market volatility, two people familiar with the ...

German drugmaker Stada Arzneimittel's private-equity owners Bain Capital and Cinven are delaying a planned initial public offering of the company until September due to recent market uncertainties ...

German pharmaceutical firm Stada is evaluating all ownership options, potentially considering an initial public offering. This decision follows reports of the company delaying its planned listing ...

STADA, a leading healthcare and pharmaceutical company in Consumer Healthcare, Generics and Specialty pharmaceuticals, continued its profitable growth journey in 2024. STADA again outperformed the ...

German pharmaceutical firm Stada said on Tuesday it was generally evaluating all options for its further ownership, including a possible initial public offering. The announcement comes after Bloomberg ...

FRANKFURT (Reuters) -German pharma firm Stada plans to launch its initial public offering (IPO) as soon as Wednesday, two people familiar with the matter said, in a test for Europe's equity markets.